Dimensional Fund Advisors
ASMB icon

Dimensional Fund Advisors’s Assembly Biosciences ASMB Stock Holding History

Dimensional Fund Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-23,682
Closed -$239K – 3482
2023
Q1 		$239K Sell
23,682
-3,209
-12% -$54.1K ﹤0.01% 3165
2022
Q4 		$419 Sell
26,891
-622
-2% -$10.6K ﹤0.01% 3075
2022
Q3 		$542K Sell
27,513
-2,064
-7% -$49.9K ﹤0.01% 3031
2022
Q2 		$745K Sell
29,577
-2,178
-7% -$50.1K ﹤0.01% 2980
2022
Q1 		$785K Sell
31,755
-14,364
-31% -$308K ﹤0.01% 3044
2021
Q4 		$1.29M Buy
46,119
+16,176
+54% +$530K ﹤0.01% 2964
2021
Q3 		$1.25M Sell
29,943
-9,156
-23% -$384K ﹤0.01% 2991
2021
Q2 		$1.82M Sell
39,099
-2,367
-6% -$117K ﹤0.01% 2892
2021
Q1 		$2.29M Sell
41,466
-1,279
-3% -$84.8K ﹤0.01% 2818
2020
Q4 		$3.1M Sell
42,745
-377
-0.9% -$44.2K ﹤0.01% 2687
2020
Q3 		$8.51M Buy
43,122
+88
+0.2% +$22.2K ﹤0.01% 2267
2020
Q2 		$12M Buy
43,034
+1,129
+3% +$263K 0.01% 2131
2020
Q1 		$7.46M Buy
41,905
+6,430
+18% +$1.38M ﹤0.01% 2248
2019
Q4 		$8.71M Buy
35,475
+6,460
+22% +$1.19M ﹤0.01% 2400
2019
Q3 		$3.42M Buy
29,015
+2,964
+11% +$448K ﹤0.01% 2718
2019
Q2 		$4.22M Buy
26,051
+9,415
+57% +$1.79M ﹤0.01% 2694
2019
Q1 		$3.93M Buy
16,636
+13,881
+504% +$3.51M ﹤0.01% 2722
2018
Q4 		$748K Buy
+2,755
New +$797K ﹤0.01% 3081
2018
Q2 		– Sell
-2,652
Closed -$1.56M – 3368
2018
Q1 		$1.56M Sell
2,652
-196
-7% -$122K ﹤0.01% 2908
2017
Q4 		$1.55M Sell
2,848
-108
-4% -$48.9K ﹤0.01% 2906
2017
Q3 		$1.24M Sell
2,956
-835
-22% -$256K ﹤0.01% 2953
2017
Q2 		$939K Hold
3,791
– – ﹤0.01% 2988
2017
Q1 		$1.16M Sell
3,791
-45
-1% -$11K ﹤0.01% 2947
2016
Q4 		$559K Buy
3,836
+381
+11% +$56.7K ﹤0.01% 3074
2016
Q3 		$299K Hold
3,455
– – ﹤0.01% 3139
2016
Q2 		$230K Hold
3,455
– – ﹤0.01% 3158
2016
Q1 		$208K Hold
3,455
– – ﹤0.01% 3176
2015
Q4 		$311K Hold
3,455
– – ﹤0.01% 3160
2015
Q3 		$396K Buy
+3,455
New +$608K ﹤0.01% 3156

Other funds holding ASMB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors's ASMB Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of Assembly Biosciences (ASMB) in Q2 2023, closing a stake of 23,682 shares — an estimated $239K sold.

Dimensional Fund Advisors first reported a position in ASMB in Q3 2015 and held it in 29 quarters. The position peaked at $12M in Q2 2020. 32 funds tracked by Wall St. Rank hold ASMB as of Q2 2023.

  • Dimensional Fund Advisors reported no remaining Assembly Biosciences position as of Q2 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 23,682 Assembly Biosciences shares in Q2 2023, an estimated $239K.
  • Dimensional Fund Advisors first reported a position in Assembly Biosciences in Q3 2015 and held it in 29 quarters.
  • Dimensional Fund Advisors's Assembly Biosciences position peaked at $12M in Q2 2020.
  • 32 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.